180
Views
10
CrossRef citations to date
0
Altmetric
Original Research

Prognosis of Early Stage Cervical Cancer According to Patterns of Recurrence

, &
Pages 8131-8136 | Published online: 28 Oct 2021

References

  • Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.2149230207593
  • Abu-Rustum NR, Yashar CM, Bean S, et al. NCCN guidelines insights: cervical cancer, version 1.2020. J Natl Compr Canc Netw. 2020;18(6):660–666. doi:10.6004/jnccn.2020.002732502976
  • Nanthamongkolkul K, Hanprasertpong J. Longer waiting times for early stage cervical cancer patients undergoing radical hysterectomy are associated with diminished long-term overall survival. J Gynecol Oncol. 2015;26(4):262–269. doi:10.3802/jgo.2015.26.4.26226404122
  • Fuglsang K, Petersen LK, Blaakaer J. Addressing challenges in future surveillance after surgery for early-stage cervical cancer. Int J Gynecol Cancer. 2015;25(2):309–314. doi:10.1097/IGC.000000000000034625594142
  • Hong JH, Tsai CS, Lai CH, et al. Recurrent squamous cell carcinoma of cervix after definitive radiotherapy. Int J Radiat Oncol Biol Phys. 2004;60(1):249–257. doi:10.1016/j.ijrobp.2004.02.04415337563
  • Jeon W, Koh HK, Kim HJ, et al. Salvage radiotherapy for lymph node recurrence after radical surgery in cervical cancer. J Gynecol Oncol. 2012;23(3):168–174. doi:10.3802/jgo.2012.23.3.16822808359
  • Zolciak-Siwinska A, Bijok M, Jonska-Gmyrek J, et al. HDR brachytherapy for the reirradiation of cervical and vaginal cancer: analysis of efficacy and dosage delivered to organs at risk. Gynecol Oncol. 2014;132(1):93–97. doi:10.1016/j.ygyno.2013.10.01824161366
  • Monk BJ, Tewari KS, Koh WJ. Multimodality therapy for locally advanced cervical carcinoma: state of the art and future directions. J Clin Oncol. 2007;25(20):2952–2965. doi:10.1200/JCO.2007.10.832417617527
  • Liontos M, Kyriazoglou A, Dimitriadis I, Dimopoulos MA, Bamias A. Systemic therapy in cervical cancer: 30 years in review. Crit Rev Oncol Hematol. 2019;137:9–17. doi:10.1016/j.critrevonc.2019.02.00931014518
  • Peiretti M, Zapardiel I, Zanagnolo V, Landoni F, Morrow CP, Maggioni A. Management of recurrent cervical cancer: a review of the literature. Surg Oncol. 2012;21(2):e59–66. doi:10.1016/j.suronc.2011.12.00822244884
  • Larson DM, Copeland LJ, Stringer CA, Gershenson DM, Malone JM Jr, Edwards CL. Recurrent cervical carcinoma after radical hysterectomy. Gynecol Oncol. 1988;30(3):381–387. doi:10.1016/0090-8258(88)90252-13391421
  • Rogers L, Siu SS, Luesley D, Bryant A, Dickinson HO. Radiotherapy and chemoradiation after surgery for early cervical cancer. Cochrane Database Syst Rev. 2012;5:CD007583.
  • Windschall A, Ott OJ, Sauer R, Strnad V. Radiation therapy and simultaneous chemotherapy for recurrent cervical carcinoma. Strahlenther Onkol. 2005;181(8):545e50. doi:10.1007/s00066-005-1340-816044224
  • Lee HN, Lee KH, Lee DW, Lee YS, Park EK, Park JS. Weekly cisplatin therapy compared with triweekly combination chemotherapy as concurrent adjuvant chemoradiation therapy after radical hysterectomy for cervical cancer. Int J Gynecol Cancer. 2011;21(1):128–136. doi:10.1097/IGC.0b013e318200f7c521330837
  • Smaniotto D, D’Agostino G, Luzi S, et al. Concurrent 5-fluorouracil, mitomycin C and radiation with or without brachytherapy in recurrent cervical cancer: a scoring system to predict clinical response and outcome. Tumori. 2005;91:295e301.16277092
  • Perez CA, Grigsby PW, Nene SM, et al. Effect of tumor size on the prognosis of carcinoma of the uterine cervix treated with irradiation alone. Cancer. 1992;69(11):2796e806. doi:10.1002/1097-0142(19920601)69:11<2796::AID-CNCR2820691127>3.0.CO;2-O1571911
  • Friedlander M, Grogan MUS. Preventative services task force. Guidelines for the treatment of recurrent and metastatic cervical cancer. Oncologist. 2002;7(4):342e7. doi:10.1634/theoncologist.2002-034212185296
  • Goto T, Kino N, Shirai T, et al. Late recurrence of invasive cervical cancer: twenty years’ experience in a single cancer institute. J Obstet Gynaecol Res. 2005;31(6):514–519. doi:10.1111/j.1447-0756.2005.00343.x16343251
  • Sobhan F, Sobhan F, Sobhan A. Recurrence of cancer cervix in patients treated by radical hysterectomy followed by adjuvant external beam radiotherapy. Bangladesh Med Res Counc Bull. 2010;36(2):52–56. doi:10.3329/bmrcb.v36i2.698721473201
  • Hanprasertpong J, Jiamset I. Late recurrence of early stage cervical cancer more than 3 years after radical hysterectomy with pelvic node dissection. Oncol Res Treat. 2017;40(5):270–276. doi:10.1159/00046440828423382
  • Kim TH, Kim MH, Kim BJ, Park SI, Ryu SY, Cho CK. Prognostic importance of the site of recurrence in patients with metastatic recurrent cervical cancer. Int J Radiat Oncol Biol Phys. 2017;98(5):1124–1131. doi:10.1016/j.ijrobp.2017.03.02928721896